Marrone Bio Innovations, Inc.
MBII
MBII was delisted on the 12th of July, 2022.
74 hedge funds and large institutions have $32.6M invested in Marrone Bio Innovations, Inc. in 2021 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 22 increasing their positions, 18 reducing their positions, and 12 closing their positions.
22% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 18
1% more funds holding
Funds holding: 73 → 74 (+1)
8% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 12
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
31% less capital invested
Capital invested by funds: $47.1M → $32.6M (-$14.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Shay Capital
New York
|
+$3.13M |
| 2 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
+$1.33M |
| 3 |
AG
Artal Group
Luxembourg
|
+$848K |
| 4 |
JG
Jefferies Group
New York
|
+$599K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$484K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$15.2M |
| 2 |
UIC
Uniplan Investment Counsel
Milwaukee,
Wisconsin
|
-$1.11M |
| 3 |
Renaissance Technologies
New York
|
-$191K |
| 4 |
OFA
Oak Family Advisors
Chicago,
Illinois
|
-$166K |
| 5 |
Morgan Stanley
New York
|
-$150K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FAIM
76
Financial Advocates Investment Management
Olympia,
Washington
| – | -$65K | -72,145 | Closed |
|
77
Marshall Wace
London,
United Kingdom
| – | -$20K | -22,182 | Closed |
|
|
CSS
78
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$19K | -20,550 | Closed |
|
79
Millennium Management
New York
| – | -$12K | -13,303 | Closed |
|
|
LWM
80
Lionsbridge Wealth Management
Jacksonville Beach,
Florida
| – | -$11K | -13,000 | Closed |
|
|
HI
81
Harbour Investments
Madison,
Wisconsin
| – | -$4K | -4,000 | Closed |
|
|
CAL
82
Capital Analysts LLC
Fort Washington,
Pennsylvania
| – | -$1K | -957 | Closed |
|
MBII Hedge Fund Activity: Q4 2021 in Review
74 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q4 2021, worth a combined $32.6M — down 31% from $47.1M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new MBII positions and 12 closed out — a net gain of 1 holder — while 22 added to existing stakes and 18 trimmed.
The largest buyer was Shay Capital, adding an estimated $3.13M. The largest seller was Macquarie Group, exiting entirely with an estimated $15.2M sold.
- 74 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q4 2021, up from 73 in Q3 2021.
- Funds reported $32.6M of Marrone Bio Innovations, Inc. stock for Q4 2021, down 31% quarter-over-quarter.
- 13 funds opened new Marrone Bio Innovations, Inc. positions in Q4 2021 and 12 closed out, a net change of +1 holder.
- The largest Marrone Bio Innovations, Inc. buyer in Q4 2021 was Shay Capital, an estimated $3.13M added.
- The largest Marrone Bio Innovations, Inc. seller in Q4 2021 was Macquarie Group, an estimated $15.2M sold.
Based on aggregated 13F filings for Q4 2021.